Pospěšme milovat lidi, neboť tak rychle odcházejí

Martina Špinková

Psychiatr. praxi. 2012;13(4):143  

ADHD from chilhood to adulthood

MUDr.Pavel Theiner, Ph.D.

Psychiatr. praxi. 2012;13(4):148-151  

ADHD is a relatively new diagnostic unit which however describes a well-known symptomatology. ADHD is a genetically determined neurodevelopmental disorder and its core symptoms (inattention, hyperactivity and impulsivity) change slightly during the life-course. The disorder begins in childhood and usually continues through adolescence into adulthood. Each developmental period possesses its own diagnostic and therapeutic particularities.

Pharmacotherapy of anxiety. Have we other possibilities than SSRI?

MUDr.Sylva Racková, Ph.D., MUDr.Luboš Janů, Ph.D.2

Psychiatr. praxi. 2012;13(4):152-155  

Anxiety disorders with lifetime prevalence 28.8 % belong among the most common illnesses. The short overview of pharmacotherapeutical possibilities other than SSRI´s (selective serotonine reuptake inhibitors) with respect to the fast onset and long-term efficacy (agomelatine, venlafaxine, duloxetine, pregabaline and some older antidepressants) are introduced in this article. Pharmaceuticals marketed in Czech republic with proved efficacy in double blind, placebo controlled studies of the most commen anxiety disorders (generalized anxiety disorder, social phobia and panic disorder) are mentioned in this summary.

Optimization of psychopharmacotherapy in schizophrenia

prof.MUDr.Eva Češková, CSc., MUDr.Michaela Vrzalová

Psychiatr. praxi. 2012;13(4):156-159  

The development of psychotropics has behind six decades and represents a significant contribution for psychiatry. Psychosis is associated with dopamine and antipsychotics strongly influence availability of dopamine. Because we have no drugs based on other mechanisms of action, we should optimize the treatment of available antipsychotics. Undoubtedly the therapeutic drug monitoring is an important tool. In the Czech Republic it is not currently used in spite of the fact, that optimal therapeutic plasma levels of antipsychotics are known and the assessment is available. Clozapine is the gold standard in the treatment of pharmacoresistant schizophrenia,...

Atypical antipsychotics and diabetes mellitus

doc.MUDr.Miroslav Zeman, CSc., doc.MUDr.Roman Jirák, CSc.

Psychiatr. praxi. 2012;13(4):160-163  

The risk of development of type 2 diabetes (DM2) is significantly increased in the patients suffering from psychotic diseases such as schizophrenia, depressive disorder or bipolar affective disorder. There are more of the causes of this phenomenon. The patients with abovementioned diseases are characterized by unhealthy lifestyle and also suffer from an increased occurence of the components of the metabolic syndrome (MetS). Treatment with some atypical antipsychotics (AAP) increases the risk of development of DM2. Atypical antipsychotics can be divided into several groups according to their influencing on the receptors of the neurotransmitters....

Depression in anxiety disorders

prof.MUDr.Eva Češková, CSc.

Psychiatr. praxi. 2012;13(4):166-168  

The co-occurrence of depression and anxiety can be perceived as a depressive episode with prominent anxiety symptoms (anxious depression) or as comorbid anxiety and depression. Furthermore, there is a question whether anxious depression represents an individual category. Some preclinical and clinical studies suggest that anxious depression has certain specific features. Anxious depression is associated with a worse outcome, chronicity, and poor treatment response. Concerning the treatment in both depressive and anxiety disorders, the first and second choice drugs are antidepressants with preference for newer antidepressants such as SSRIs and...

Depression and epilepsy

MUDr.Anežka Ticháčková

Psychiatr. praxi. 2012;13(4):169-173  

Depressive disorders are frequent psychiatric comorbidities in epilepsy. They distinguish from depression in common population, they are often unrecognized and untreated. Depressive disorders affect subsequent course and result of epilepsy treatment.

Impact of new laws effective from 2012 on forensic psychiatric practice

MUDr.Jiří Švarc, Ph.D.

Psychiatr. praxi. 2012;13(4):182-184  

The article highlights some new legal provisions in the Health Services Act, relevant to forensic psychiatric practice, such as viewing of medical records by private experts, the problematic consent of a minor and legally incompetent person to hospitalization and other procedures (medication), new notification obligations, or a new definition of containment methods; by contrast, the regulation concerning duty of confidentiality remains unchanged. The possibility of performing sterilization, therapeutic castration, and others is newly regulated in the Act on Specific Health Services. In accordance with the amendment to the Criminal Code, it...

Cognitive behavioral therapy of panic disorder in group

MUDr.Dana Kamarádová, prof.MUDr.Ján Praško, CSc.

Psychiatr. praxi. 2012;13(4):174-181  

In this article we describe step by step the cognitive-behavioral group therapy of patients with panic disorder. We are explaning the concept of cognitive model of panic disorder, vicious circle, cognitive reconstruction, control of breathing and exposure. In the article we also present personal experience with group cognitive-behavioral therapy and stories of patients who have undergone the therapy. We also try to point to possible complications that may occur during the therapy. solving.

Absence of psychosocial intervention on discharge from inpatient facilities

Ing.Josef Závišek

Psychiatr. praxi. 2012;13(4):185-186  

The aim of the article is to show the need for connecting health and social services for individuals with a mental disorder, particularly those with a psychotic disorder. It shows, what conditions must be met by subsequent inpatient care for the mentally ill in order for the treatment to be comprehensive and establish services for the patient that have to be provided following discharge in accordance with the valid legislation. Social Services Act, Health Services Act.

Autodidaktický test 4/2012

Psychiatr. praxi. 2012;13(4):187